Protein Timing and Dose for Older Adults: What Actually Matters

Older adults can hit a higher protein target, drink a shake after training, and still see little change in muscle mass. That result is not a failure of effort. In a systematic review and meta-analysis of randomized trials limited to adults 65 and older, protein supplementation alone did not significantly improve lean mass, fat-free mass, or appendicular lean mass. Free essential amino acids (EAAs), creatine monohydrate, and HMB did produce significant gains in the pooled analysis.

The finding does not mean protein is useless. It means total daily grams are only one part of the problem. Aging muscle responds less strongly to feeding, and the form, leucine content, meal pattern, food matrix, adherence, training, and baseline health status can all change the outcome. Protein is still food, not a magic spell; but it is also not interchangeable with every amino-acid strategy.

Protein dose matters, but aging changes the response

A 2024 randomized controlled trial in older men found that the muscle-protein-synthesis response to protein and amino-acid feeding can be reduced by as much as about 30% compared with younger adults. The authors describe muscle protein synthesis as a graded, saturable process: increasing protein can increase the response, but not indefinitely. Per-meal protein dose, protein quality, and distribution across the day each predicted the response. The study also concluded that the current RDA of 0.8 g/kg/day does not adequately account for this age-related anabolic resistance.

That supports a practical distinction often lost in protein advice. Older adults should not treat the daily total as the only target. A very high-protein dinner cannot necessarily make up for meals that provide too little usable amino acid stimulus earlier in the day. Still, the trial measured integrated myofibrillar protein synthesis, not years of muscle gain or disability outcomes. A higher short-term synthesis rate is a useful physiological signal, not proof that a supplement will preserve independence.

The McKendry et al. randomized trial makes the sensible case for more protein than the RDA in many older adults. It does not establish an exact universal protein dose, a per-meal leucine threshold in milligrams, or a guaranteed muscle-building response for every person over 65.

Why free EAAs may outperform intact protein in trials

The strongest outcome-level evidence comes from the 2021 Martin-Cantero et al. meta-analysis. It included randomized controlled trials in adults at least 65 years old and assessed lean mass, fat-free mass, and appendicular lean mass. Protein supplementation alone did not reach statistical significance for those muscle-mass outcomes, while free EAAs, creatine monohydrate, and HMB did. The review also identified longer intervention duration, adherence above 80%, dose, and administration frequency as factors associated with more favorable effects.

Those moderators matter. A short trial with poor adherence can make a useful intervention look ineffective. But the pooled pattern still argues against selling intact protein supplementation as a stand-alone muscle-preservation plan for all older adults.

Leucine helps explain why formulation may matter. A 2023 systematic review by Wilkinson et al. supports the leucine-threshold hypothesis: dietary leucine content is closely tied to post-meal and post-exercise muscle protein synthesis. Leucine helps activate mTORC1, a signaling pathway involved in muscle protein synthesis. The exact threshold likely varies by person and context, and no study in this evidence base directly established a specific threshold for adults over 65.

Free EAAs deliver leucine without requiring digestion of an intact protein matrix. That is a plausible advantage, especially after exercise, but it remains a mechanistic interpretation rather than a direct head-to-head proof that every older adult needs EAAs instead of whey or food. A 2025 trial of dileucine-supplemented EAAs found greater resting myofibrillar protein synthesis and better whole-body anabolism after resistance exercise than an equivalent amount of free leucine. However, the study did not provide older-adult-specific results, so it cannot yet justify a dileucine protocol for anabolic resistance after 65.

Food matrix can change the same protein dose

Protein quantity on a nutrition label does not tell you how quickly amino acids reach circulation. In a randomized trial of healthy adults, a lipid-rich meat matrix blunted the post-exercise increase in myofibrillar protein synthesis despite matching the comparator for total protein. The 2025 Zupančič et al. trial did not study older adults, so it cannot prove that fatty foods cause anabolic resistance in that group. It does show that food composition can alter the post-exercise response even when protein grams match.

For someone using intact protein around resistance exercise, a lower-fat, rapidly digested option is a reasonable choice. That is a timing-and-matrix decision, not a license to declare whole foods bad. A steak dinner can contribute high-quality protein; it simply may not produce the same immediate amino-acid kinetics as a low-fat protein drink or free EAA product.

Creatine and HMB address different parts of the problem

The meta-analysis found significant muscle-mass gains with creatine and HMB, unlike protein alone. These interventions do not duplicate EAAs. Creatine supports the phosphocreatine system and has been linked to muscle-related adaptations through pathways distinct from amino-acid delivery. HMB, a leucine metabolite, appears to reduce muscle protein breakdown through ubiquitin-proteasome pathways while also influencing mTOR signaling.

A 2024 International Society of Sports Nutrition position stand supports HMB use in aging populations at 3 g/day. That recommendation deserves some restraint: parts of the HMB literature include industry funding, much of the dosing evidence comes from shorter studies, and durable benefits without resistance training remain uncertain. HMB can be a reasonable adjunct, not an excuse to skip training.

Exercise changes the equation. A 2023 systematic review of sarcopenic older adults found that exercise programs combined with dietary supplementation improved body composition and physical function, while supplementation without exercise had smaller effects. Nutrition provides substrate and signals. Resistance exercise tells muscle why it should use them.

Why "protein does not work" goes too far

Two lines of evidence prevent a blanket dismissal of intact protein. First, Mathewson et al. reported cross-sectional associations between habitual dietary protein intake and physiological muscle measures in younger and older people. Association cannot establish causation, but it fits the uncontroversial conclusion that chronic protein adequacy remains relevant.

Second, a double-blind, placebo-controlled trial in well-nourished older adults found no robust gains in muscle mass, strength, physical performance, or muscle protein synthesis from leucine-enriched intact protein, either alone or combined with fish-oil-derived omega-3s. The Murphy et al. trial weakens the simplistic advice to add leucine to any shake and expect a fix. Yet it studied well-nourished adults, not people with low protein intake or clinical sarcopenia.

That distinction may matter. A 2025 study in sarcopenic individuals suggests leucine and whey protein can improve muscle quality in that population. The available description does not support a universal claim that whey reverses sarcopenia, but it does show that baseline condition can change responsiveness. Healthy aging, protein insufficiency, and diagnosed sarcopenia should not be treated as the same clinical situation.

There is biological variation, too. In lean, anabolically sensitive older men, Horwath et al. found higher expression of amino-acid sensors and mTORC1 activators than in young controls. That subgroup finding argues against a universal upstream nutrient-sensing defect. In less responsive older adults, the bottleneck may lie farther downstream in translation or ribosomal capacity, but that explanation still needs direct testing.

A practical, evidence-calibrated plan

• Target daily protein above 0.8 g/kg/day, with individualized guidance for kidney disease, frailty, appetite loss, or other medical conditions.
• Spread protein across meals and prioritize protein quality and leucine-rich choices rather than concentrating nearly all protein at dinner.
• Make progressive resistance exercise the foundation. Supplements have weaker effects without it.
• Consider free EAAs around training if the goal is a rapid amino-acid stimulus and food intake alone is difficult to distribute.
• Consider creatine monohydrate or HMB as add-ons, not replacements for diet and training. HMB evidence supports 3 g/day, with the caveats above.
• If using intact protein after exercise, a lower-fat, rapidly digested option may be more suitable than a lipid-rich meal when immediate muscle protein synthesis is the aim.

For adults over 65, the evidence supports a layered strategy: adequate daily protein, meaningful per-meal delivery, resistance exercise, and—when appropriate—EAAs, creatine, or HMB. The meta-analysis does not show that protein is irrelevant. It shows that protein alone often fails to clear every barrier aging muscle puts in its way.

The central meta-analysis searched literature through November 2017, so it misses newer formulation studies and may not fully reflect current products or trial designs. It also combines trials that differed in duration, adherence, dose, frequency, and participant health. The honest conclusion is narrower than supplement marketing: optimize protein, but do not expect timing or a bigger scoop to solve anabolic resistance by itself.